Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2074459

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2074459

Rapid Microbiology Testing Market by Product (Instruments (Mass Spectrometers), Consumables), Method (Nucleic Acid-based), Application (Industrial Testing (Food & Beverage), Clinical Diagnosis), End User (Hospitals), & Region - Global Forecast to 2031

PUBLISHED:
PAGES: 436 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The market for rapid microbiology testing is projected to grow from USD 5.69 billion in 2026 to USD 9.00 billion by 2031, reflecting a CAGR of 9.6%. Market growth is supported by rising pharmaceutical and biopharmaceutical production, stringent sterility and contamination control requirements, and expanding use of molecular diagnostics and automated microbiology systems.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsProduct, Method, Application, End User, Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East, Africa

Additionally, advancements in Polymerase Chain Reaction (PCR), mass spectrometry, and rapid microbial identification technologies are improving laboratory efficiency and supporting broader adoption globally.

Rapid Microbiology Testing Market - IMG1

"By product, reagents & Kits segment to showcase highest CAGR during forecast period"

The growth of the reagents & kits segment is primarily driven by the recurring demand for culture media, assay kits, primers, probes, stains, buffers, and antimicrobial susceptibility testing reagents used in rapid microbiology workflows. Rising incidences of infectious diseases and increasing emphasis on sterility assurance and contamination control are accelerating testing volumes across hospitals, pharmaceutical & biotechnology companies, and food testing laboratories. Additionally, expanding adoption of molecular microbiology techniques, automated testing platforms, and rapid PCR-based assays is expected to further drive demand for reagents & kits throughout the forecast period.

"By method, growth-based segment to hold the largest share of rapid microbiology testing market in 2026"

A growth-based rapid microbiology testing method is likely to dominate the market in 2026 due to its extensive use in pharmaceutical sterility testing, environmental monitoring, food safety testing, and clinical microbiology workflows. Growth-based rapid microbiology methods are widely adopted because they provide reliable detection of viable microorganisms while supporting regulatory compliance and quality assurance requirements. The increasing adoption of automated microbial detection systems, rising demand for faster contamination identification, and growing pharmaceutical and biopharmaceutical manufacturing activities are further driving segment growth. Additionally, the need for rapid product release and improved laboratory efficiency continues to support demand for growth-based testing methods.

"Asia Pacific to register fastest growth rate in rapid microbiology testing market during forecast period"

The region is witnessing significant growth due to expanding healthcare infrastructure, increasing healthcare expenditure, and rapid modernization of hospitals, diagnostic laboratories, and pharmaceutical manufacturing facilities. Rising prevalence of infectious diseases and growing awareness regarding contamination control and patient safety are increasing the demand for rapid microbial diagnostics across the region. Additionally, increasing investments in biotechnology research, biopharmaceutical production, and laboratory automation are further supporting market expansion. The growing adoption of molecular diagnostics, rapid PCR systems, and automated microbial identification technologies is also contributing to market growth. Major countries driving regional expansion include China, India, Japan, and South Korea.

Breakdown of primary participants in the rapid microbiology testing market is as follows:

  • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
  • By Designation: C-level Executives (27%), Directors (18%), and Other Designations (55%)
  • By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and the Middle East & Africa (4%)

The key players in the rapid microbiology testing market are bioMerieux (France), Waters Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Bruker Corporation (US), QuidelOrtho Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Charles River Laboratories International, Inc. (US), Neogen Corporation (US), Bio-Rad Laboratories, Inc. (US), Shimadzu Corporation (Japan), and Rapid Micro Biosystems, Inc. (US).

Research Coverage:

This research report categorizes the rapid microbiology testing market by product (consumables, instruments, reagents & kits), method (growth-based, cellular component-based, nucleic acid-based, viability-based, and other methods) application (industrial testing, clinical disease diagnosis, and research applications), end user (hospitals, clinical laboratories, & ASCs; pharmaceutical & biotechnology companies; food & beverage companies; environmental & water testing laboratories; and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the rapid microbiology testing market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, solutions, and key strategies, such as partnerships, collaborations, expansions, agreements, product launches, and recent developments in the rapid microbiology testing market. This report covers the competitive analysis of upcoming startups in the rapid microbiology testing ecosystem.

Reasons to Buy This Report:

The report will help leaders/new entrants in this market by providing information on the closest approximations of revenue for the overall rapid microbiology testing market and its subsegments. This report will help stakeholders understand the competitive landscape and gain deeper insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers (increasing burden of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases; technological advancements in automated microbiology and MALDI-TOF platforms; growing food safety concerns and rising incidence of foodborne illnesses; increasing R&D activities in microbiology and infectious disease), restraints (high capital investments and low cost-benefit ratio, unfavorable regulatory and reimbursement scenario, shortage of skilled personnel), opportunities (growing demand for rapid microbiology testing in emerging economies, expansion of rapid microbial testing applications), and challenges (operational barriers, high investment for automated microbial identification systems)
  • Product development/innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the rapid microbiology testing market.
  • Market development: Comprehensive information about lucrative markets; the report analyzes the rapid microbiology testing market across varied regions.
  • Market diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the rapid microbiology testing market.
  • Competitive assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like bioMerieux (France), Waters Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), and Thermo Fisher Scientific, Inc. (US).
Show more
Product Code: MD 6602

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING MARKET
  • 2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 RAPID MICROBIOLOGY TESTING MARKET OVERVIEW
  • 3.2 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2026 VS. 2031
  • 3.3 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2026 VS. 2031
  • 3.4 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2026 VS. 2031
  • 3.5 RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2026 VS. 2031
  • 3.6 RAPID MICROBIOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Increasing burden of healthcare-associated infections (HAIs), antimicrobial resistance (AMR), and infectious diseases
      • 4.2.1.2 Technological advancements in automated microbiology and MALDI-TOF platforms
      • 4.2.1.3 Growing food safety concerns and rising incidence of foodborne illnesses
      • 4.2.1.4 Increasing R&D in microbiology and infectious diseases
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High capital investments and low cost-benefit ratio
      • 4.2.2.2 Unfavorable regulatory and reimbursement scenario
      • 4.2.2.3 Shortage of skilled personnel
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Growing demand for rapid microbiology testing in emerging economies
      • 4.2.3.2 Expansion of rapid microbial testing applications
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Operational barriers
      • 4.2.4.2 High investment for automated microbial identification systems
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN RAPID MICROBIOLOGY TESTING MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF NEW ENTRANTS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
  • 5.3 SUPPLY CHAIN ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
    • 5.5.1 RAPID MICROBIOLOGY TESTING MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • 5.6 PRICING ANALYSIS
    • 5.6.1 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY KEY PLAYER, 2024-2026
    • 5.6.2 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION, 2024-2026
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT SCENARIO (HS CODE 3822)
    • 5.7.2 EXPORT SCENARIO (HS CODE 3822)
  • 5.8 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.10 INVESTMENT & FUNDING SCENARIO
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 YOUNGS SEAFOOD ACCELERATED FOOD TESTING WITH VIDAS
    • 5.11.2 RAPID MICROBIOLOGICAL METHOD CASE STUDY FOR ADVANCED THERAPY MEDICINAL PRODUCTS
    • 5.11.3 RAPID DETECTION METHOD OF BACTERIAL PATHOGENS IN SURFACE WATERS AND NEW RISK INDICATOR FOR WATER PATHOGENIC POLLUTION
  • 5.12 IMPACT OF US TARIFFS-RAPID MICROBIOLOGY TESTING MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 IMPACT ON COUNTRIES/REGIONS
      • 5.12.4.1 North America
      • 5.12.4.2 Europe
      • 5.12.4.3 Asia Pacific
    • 5.12.5 IMPACT ON END-USE INDUSTRIES
      • 5.12.5.1 Hospitals, Clinical Laboratories, and ASCs
      • 5.12.5.2 Pharmaceutical & Biotechnology Companies
      • 5.12.5.3 Food & Beverage Companies
      • 5.12.5.4 Environmental & Water Testing Laboratories

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 AUTOMATED MULTIPLEX PCR SYSTEMS
    • 6.1.2 BIOSENSORS
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 OPTICAL IMMUNOSENSORS
    • 6.2.2 ELECTROCHEMICAL IMMUNOSENSORS
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 DIGITAL PCR (DPCR)
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.5 PATENT ANALYSIS
    • 6.5.1 LIST OF MAJOR PATENTS
  • 6.6 FUTURE APPLICATIONS
  • 6.7 IMPACT OF AI/GENERATIVE AI ON RAPID MICROBIOLOGY TESTING MARKET
    • 6.7.1 INTRODUCTION
    • 6.7.2 TOP USE CASES AND MARKET POTENTIAL
    • 6.7.3 KEY COMPANIES IMPLEMENTING AI
    • 6.7.4 FUTURE OF AI

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN RAPID MICROBIOLOGY TESTING
      • 7.2.1.1 Eco-friendly Initiatives
  • 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
  • 8.5 MARKET PROFITABILITY
    • 8.5.1 REVENUE POTENTIAL
    • 8.5.2 COST DYNAMICS
    • 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT

  • 9.1 INTRODUCTION
  • 9.2 INSTRUMENTS
    • 9.2.1 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
      • 9.2.1.1 Ease of use compared to conventional identification processes to support market growth
    • 9.2.2 MASS SPECTROMETERS
      • 9.2.2.1 Rapid results associated with mass spectrometry methods to boost adoption
    • 9.2.3 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS
      • 9.2.3.1 Unwanted detection of non-microbial ATP to limit market adoption
    • 9.2.4 PCR SYSTEMS
      • 9.2.4.1 Growing use of standard, real-time, and qPCR for rapid microbial testing to support growth
    • 9.2.5 CYTOMETERS
      • 9.2.5.1 Ability to detect viable organisms to favor market growth
    • 9.2.6 ACTIVE AIR SAMPLERS
      • 9.2.6.1 Convenience and ease of use to drive demand for active air samplers
    • 9.2.7 OTHER INSTRUMENTS
  • 9.3 REAGENTS & KITS
    • 9.3.1 STERILITY TESTING REAGENTS & KITS
      • 9.3.1.1 Increasing adoption of BET assays to propel market growth
    • 9.3.2 OTHER REAGENTS & KITS
  • 9.4 CONSUMABLES
    • 9.4.1 DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH

10 RAPID MICROBIOLOGY TESTING MARKET: VOLUME ANALYSIS

  • 10.1 INTRODUCTION
  • 10.2 GLOBAL: VOLUME OF MALDI-TOF MS MICROBIAL IDENTIFICATION SYSTEM INSTALLED BASE

11 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD

  • 11.1 INTRODUCTION
  • 11.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING
    • 11.2.1 RISING DEMAND FOR GROWTH-BASED TESTING TO DRIVE MARKET
  • 11.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
    • 11.3.1 HIGH SENSITIVITY, ACCURACY, AND SPECIFICITY OF CELLULAR COMPONENT-BASED METHODS TO BOOST MARKET
  • 11.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
    • 11.4.1 HIGH ACCURACY ASSOCIATED WITH NUCLEIC ACID-BASED METHODS TO FAVOR MARKET GROWTH
  • 11.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING
    • 11.5.1 NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY TO DRIVE DEMAND
  • 11.6 OTHER METHODS

12 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION

  • 12.1 INTRODUCTION
  • 12.2 INDUSTRIAL TESTING
    • 12.2.1 FOOD & BEVERAGE TESTING
      • 12.2.1.1 Stringent quality control and quality assurance processes to drive market growth
    • 12.2.2 PHARMACEUTICAL & BIOLOGICAL DRUG TESTING
      • 12.2.2.1 Improved regulatory scenario for drug development to support market growth
    • 12.2.3 ENVIRONMENTAL TESTING
      • 12.2.3.1 Growing focus on environmental monitoring to boost segmental growth
    • 12.2.4 COSMETIC & PERSONAL CARE PRODUCTS TESTING
      • 12.2.4.1 Growing use of rapid microbiology testing to determine the presence of microbes favors market growth
    • 12.2.5 OTHER INDUSTRIAL TESTING APPLICATIONS
  • 12.3 CLINICAL DISEASE DIAGNOSIS
    • 12.3.1 HIGH BURDEN OF INFECTIOUS DISEASES AND HEALTHCARE-ASSOCIATED INFECTIONS TO PROPEL MARKET GROWTH
  • 12.4 RESEARCH
    • 12.4.1 INCREASING NUMBER OF EPIDEMIOLOGY-BASED RESEARCH STUDIES TO DRIVE MARKET GROWTH

13 RAPID MICROBIOLOGY TESTING MARKET, BY END USER

  • 13.1 INTRODUCTION
  • 13.2 HOSPITALS, CLINICAL LABORATORIES, AND ASCS
    • 13.2.1 INCREASING PATIENT VOLUME AND RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 13.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 13.3.1 STRINGENT GMP AND CONTAMINATION CONTROL REQUIREMENTS TO DRIVE TESTING DEMAND
  • 13.4 FOOD & BEVERAGE COMPANIES
    • 13.4.1 STRINGENT FOOD SAFETY REGULATIONS AND QUALITY CONTROL TO SUPPORT MARKET GROWTH
  • 13.5 ENVIRONMENTAL & WATER TESTING LABORATORIES
    • 13.5.1 GROWING FOCUS ON WATER SAFETY AND ENVIRONMENTAL MONITORING TO DRIVE DEMAND
  • 13.6 OTHER END USERS

14 RAPID MICROBIOLOGY TESTING MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
    • 14.2.2 US
      • 14.2.2.1 Increasing prevalence of infectious diseases to drive market
    • 14.2.3 CANADA
      • 14.2.3.1 Supportive government initiatives and increased research funding to boost market
  • 14.3 EUROPE
    • 14.3.1 EUROPE: MACROECONOMIC OUTLOOK
    • 14.3.2 GERMANY
      • 14.3.2.1 Favorable government policies to propel market
    • 14.3.3 FRANCE
      • 14.3.3.1 Favorable healthcare reforms and investments in diagnostic infrastructure to drive market
    • 14.3.4 UK
      • 14.3.4.1 Emphasis on food contamination monitoring and hygiene controls to drive market
    • 14.3.5 ITALY
      • 14.3.5.1 Improved healthcare services and better disease surveillance to support market growth
    • 14.3.6 SPAIN
      • 14.3.6.1 Water monitoring mandate to boost market growth
    • 14.3.7 RUSSIA
      • 14.3.7.1 Strengthening water quality surveillance and outbreak response drives adoption in Russia
    • 14.3.8 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 14.4.2 CHINA
      • 14.4.2.1 Increasing government focus on disease prevention to drive market
    • 14.4.3 JAPAN
      • 14.4.3.1 Stringent safety laws and foodborne outbreaks to fuel uptake
    • 14.4.4 INDIA
      • 14.4.4.1 High target patient population to boost demand
    • 14.4.5 SOUTH KOREA
      • 14.4.5.1 Favorable government initiatives for medical tourism to support market growth
    • 14.4.6 AUSTRALIA
      • 14.4.6.1 Favorable healthcare automation techniques to support market growth
    • 14.4.7 REST OF ASIA PACIFIC
  • 14.5 LATIN AMERICA
    • 14.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
    • 14.5.2 BRAZIL
      • 14.5.2.1 Improving healthcare infrastructure and stringent regulations to fuel market
    • 14.5.3 MEXICO
      • 14.5.3.1 Increasing prevalence of HIV to drive market
    • 14.5.4 REST OF LATIN AMERICA
  • 14.6 MIDDLE EAST & AFRICA
    • 14.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
    • 14.6.2 SAUDI ARABIA
      • 14.6.2.1 Increasing focus on healthcare automation to drive market
    • 14.6.3 UNITED ARAB EMIRATES (UAE)
      • 14.6.3.1 Improvements in healthcare infrastructure to support market growth
    • 14.6.4 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

  • 15.1 INTRODUCTION
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET
  • 15.3 REVENUE ANALYSIS, 2023-2025
  • 15.4 MARKET SHARE ANALYSIS, 2025
    • 15.4.1 GLOBAL MARKET SHARE ANALYSIS, 2025
  • 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.5.1 STARS
    • 15.5.2 EMERGING LEADERS
    • 15.5.3 PERVASIVE PLAYERS
    • 15.5.4 PARTICIPANTS
    • 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 15.5.5.1 Company footprint
      • 15.5.5.2 Region footprint
      • 15.5.5.3 Product footprint
      • 15.5.5.4 Application footprint
      • 15.5.5.5 End-user footprint
  • 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 15.6.1 PROGRESSIVE COMPANIES
    • 15.6.2 RESPONSIVE COMPANIES
    • 15.6.3 DYNAMIC COMPANIES
    • 15.6.4 STARTING BLOCKS
    • 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 15.6.5.1 Detailed list of key startups/SMEs
      • 15.6.5.2 Competitive benchmarking of startups/SMEs
  • 15.7 COMPANY VALUATION & FINANCIAL METRICS
    • 15.7.1 FINANCIAL METRICS
    • 15.7.2 COMPANY VALUATION
  • 15.8 BRAND/PRODUCT COMPARISON
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES & APPROVALS
    • 15.9.2 DEALS
    • 15.9.3 EXPANSIONS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 BIOMERIEUX
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Product launches & approvals
        • 16.1.1.3.2 Deals
        • 16.1.1.3.3 Other developments
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Right to win
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses & competitive threats
    • 16.1.2 WATERS CORPORATION
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Product approvals
        • 16.1.2.3.2 Deals
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Right to win
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses & competitive threats
    • 16.1.3 DANAHER CORPORATION
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Product approvals
        • 16.1.3.3.2 Deals
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Right to win
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses & competitive threats
    • 16.1.4 ABBOTT LABORATORIES
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products offered
      • 16.1.4.3 Recent developments
        • 16.1.4.3.1 Product approvals
      • 16.1.4.4 MnM view
        • 16.1.4.4.1 Right to win
        • 16.1.4.4.2 Strategic choices
        • 16.1.4.4.3 Weaknesses & competitive threats
    • 16.1.5 THERMO FISHER SCIENTIFIC INC.
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Product launches
        • 16.1.5.3.2 Deals
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Right to win
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses & competitive threats
    • 16.1.6 BRUKER CORPORATION
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Product launches & approvals
        • 16.1.6.3.2 Deals
    • 16.1.7 QUIDELORTHO CORPORATION
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Product launches & approvals
        • 16.1.7.3.2 Deals
        • 16.1.7.3.3 Expansions
    • 16.1.8 SARTORIUS AG
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products offered
    • 16.1.9 MERCK KGAA
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products offered
      • 16.1.9.3 Recent developments
        • 16.1.9.3.1 Product launches & approvals
    • 16.1.10 F. HOFFMANN-LA ROCHE LTD
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products offered
      • 16.1.10.3 Recent developments
        • 16.1.10.3.1 Product launches & approvals
        • 16.1.10.3.2 Deals
    • 16.1.11 CHARLES RIVER LABORATORIES, INC.
      • 16.1.11.1 Business overview
      • 16.1.11.2 Products offered
      • 16.1.11.3 Recent developments
        • 16.1.11.3.1 Product launches
        • 16.1.11.3.2 Deals
    • 16.1.12 NEOGEN CORPORATION
      • 16.1.12.1 Business overview
      • 16.1.12.2 Products offered
      • 16.1.12.3 Recent developments
        • 16.1.12.3.1 Product launches
    • 16.1.13 BIO-RAD LABORATORIES, INC.
      • 16.1.13.1 Business overview
      • 16.1.13.2 Products offered
      • 16.1.13.3 Recent developments
        • 16.1.13.3.1 Product launches & approvals
        • 16.1.13.3.2 Deals
    • 16.1.14 SHIMADZU CORPORATION
      • 16.1.14.1 Business overview
      • 16.1.14.2 Products offered
      • 16.1.14.3 Recent developments
        • 16.1.14.3.1 Expansions
    • 16.1.15 RAPID MICRO BIOSYSTEMS, INC.
      • 16.1.15.1 Business overview
      • 16.1.15.2 Products offered
      • 16.1.15.3 Recent developments
        • 16.1.15.3.1 Deals
  • 16.2 OTHER PLAYERS
    • 16.2.1 DON WHITLEY SCIENTIFIC LIMITED
    • 16.2.2 GRADIENTECH
    • 16.2.3 RQMICRO AG
    • 16.2.4 COLIFAST AS
    • 16.2.5 HYGIENA LLC
    • 16.2.6 COPAN DIAGNOSTICS INC.
    • 16.2.7 PERKINELMER INC.
    • 16.2.8 HARDY DIAGNOSTICS
    • 16.2.9 CHARM SCIENCES
    • 16.2.10 R-BIOPHARM

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH DATA
  • 17.2 RESEARCH APPROACH
    • 17.2.1 SECONDARY RESEARCH
      • 17.2.1.1 Key data from secondary sources
    • 17.2.2 PRIMARY DATA
      • 17.2.2.1 Primary sources
      • 17.2.2.2 Key data from primary sources
      • 17.2.2.3 Key industry insights
  • 17.3 MARKET SIZE ESTIMATION
    • 17.3.1 BOTTOM-UP APPROACH
      • 17.3.1.1 Approach 1: Company revenue estimation approach
      • 17.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 17.3.1.3 Growth forecast
    • 17.3.2 TOP-DOWN APPROACH
  • 17.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 17.5 MARKET SHARE ANALYSIS
  • 17.6 RESEARCH ASSUMPTIONS
    • 17.6.1 PARAMETRIC ASSUMPTIONS
    • 17.6.2 GROWTH RATE ASSUMPTIONS
  • 17.7 RESEARCH LIMITATIONS
  • 17.8 RISK ASSESSMENT

18 APPENDIX

  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS
Show more
Product Code: MD 6602

List of Tables

  • TABLE 1 ESTIMATED NUMBER OF PEOPLE LIVING WITH HIV, ALL AGES, 2010, 2023, AND 2024 (MILLION PEOPLE)
  • TABLE 2 TOTAL TUBERCULOSIS INCIDENCE, BY REGION, 2024
  • TABLE 3 US: FOOD RECALLS AND REASONS, 2025
  • TABLE 4 US: FOOD RECALLS, BY SPECIES, 2025
  • TABLE 5 RAPID MICROBIOLOGY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 6 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023-2030
  • TABLE 7 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 8 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 9 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 10 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 11 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 12 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY KEY PLAYER, 2024-2026 (USD)
  • TABLE 13 AVERAGE SELLING PRICE OF RAPID MICROBIOLOGY TESTING PRODUCTS, BY REGION, 2024-2026 (USD)
  • TABLE 14 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 15 EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 16 RAPID MICROBIOLOGY TESTING MARKET: KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 17 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 18 LIST OF MAJOR PATENTS PERTAINING TO RAPID MICROBIOLOGY TESTING MARKET, 2023-2025
  • TABLE 19 KEY COMPANIES IMPLEMENTING AI IN RAPID MICROBIOLOGY TESTING MARKET
  • TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 GLOBAL STANDARDS IN THE RAPID MICROBIOLOGY TESTING MARKET
  • TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%)
  • TABLE 27 KEY BUYING CRITERIA, BY PRODUCT
  • TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • TABLE 29 RAPID MICROBIOLOGY TESTING MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
  • TABLE 30 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 31 KEY PRODUCTS IN RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET
  • TABLE 32 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 33 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 34 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 35 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 37 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 38 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 39 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 40 NORTH AMERICA: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 EUROPE: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 43 LATIN AMERICA: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 MIDDLE EAST & AFRICA: AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 45 MASS SPECTROMETERS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 46 NORTH AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 47 EUROPE: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 49 LATIN AMERICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 50 MIDDLE EAST & AFRICA: MASS SPECTROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 52 NORTH AMERICA: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 53 EUROPE: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 55 LATIN AMERICA: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 56 MIDDLE EAST & AFRICA: BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 57 PCR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 58 NORTH AMERICA: PCR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 59 EUROPE: PCR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: PCR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 LATIN AMERICA: PCR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 62 MIDDLE EAST & AFRICA: PCR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 63 CYTOMETERS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 64 NORTH AMERICA: CYTOMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 65 EUROPE: CYTOMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: CYTOMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 67 LATIN AMERICA: CYTOMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 68 MIDDLE EAST & AFRICA: CYTOMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 69 ACTIVE AIR SAMPLERS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 70 NORTH AMERICA: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 71 EUROPE: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 73 LATIN AMERICA: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 74 MIDDLE EAST & AFRICA: ACTIVE AIR SAMPLERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 75 OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 76 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 77 EUROPE: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 79 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 80 MIDDLE EAST & AFRICA: OTHER RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 81 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 82 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 83 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 84 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 86 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 87 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 88 STERILITY TESTING REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 89 NORTH AMERICA: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 90 EUROPE: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 92 LATIN AMERICA: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 93 MIDDLE EAST & AFRICA: STERILITY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 94 OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 95 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 96 EUROPE: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 98 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 99 MIDDLE EAST & AFRICA: OTHER RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 100 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 101 NORTH AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 102 EUROPE: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 104 LATIN AMERICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 105 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 106 GLOBAL: MALDI-TOF MS MICROBIAL IDENTIFICATION SYSTEM INSTALLED BASE VOLUME, 2024-2031 (UNITS)
  • TABLE 107 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 108 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS
  • TABLE 109 GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 110 NORTH AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 111 EUROPE: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 113 LATIN AMERICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 114 MIDDLE EAST & AFRICA: GROWTH-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 115 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 116 NORTH AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 117 EUROPE: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 119 LATIN AMERICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 120 MIDDLE EAST & AFRICA: CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 121 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 122 NORTH AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 123 EUROPE: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 125 LATIN AMERICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 126 MIDDLE EAST & AFRICA: NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 127 VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 128 NORTH AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 129 EUROPE: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 131 LATIN AMERICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 132 MIDDLE EAST & AFRICA: VIABILITY-BASED RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 133 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 134 NORTH AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 135 EUROPE: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 137 LATIN AMERICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 138 MIDDLE EAST & AFRICA: OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 139 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 140 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 141 RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 142 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 143 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 144 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 145 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 146 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 147 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 148 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 149 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 151 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 152 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 153 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 154 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 155 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 157 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 158 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 159 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 160 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 161 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 163 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 165 QUALITY REGULATIONS & STANDARDS FOR COSMETICS & PERSONAL CARE
  • TABLE 166 RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 167 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 168 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 170 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR COSMETIC & PERSONAL CARE PRODUCT TESTING, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 172 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 173 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 174 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 176 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER INDUSTRIAL TESTING APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 178 RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 179 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 180 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 182 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 184 RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 185 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 186 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 188 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 189 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR RESEARCH, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 190 RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 191 RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, & ASCS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 192 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 193 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 194 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 195 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 196 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR HOSPITALS, CLINICAL LABORATORIES, AND ASCS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 197 RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 198 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 199 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 200 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 201 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 202 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 203 RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 204 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 205 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 206 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 207 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 208 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 209 RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 210 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 211 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 213 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL & WATER TESTING LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 215 RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 216 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 217 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 219 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 221 RAPID MICROBIOLOGY TESTING MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 222 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 223 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 224 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 225 NORTH AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 226 NORTH AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 227 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 228 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 229 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 231 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 232 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 233 US: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 234 US: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 235 US: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 236 US: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 237 US: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 238 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 239 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 240 CANADA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 241 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 242 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 243 CANADA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 244 CANADA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 245 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 246 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 247 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 248 EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 249 EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 250 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 251 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 252 EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 253 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 254 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 255 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 256 GERMANY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 257 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 258 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 259 GERMANY: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 260 GERMANY: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 261 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 262 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 263 FRANCE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 264 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 265 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 266 FRANCE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 267 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 268 UK: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 269 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 270 UK: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 271 UK: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 272 UK: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 273 UK: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 274 UK: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 275 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 276 ITALY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 277 ITALY: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 278 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 279 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 280 ITALY: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 281 ITALY: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 282 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 283 SPAIN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 284 SPAIN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 286 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 287 SPAIN: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 288 SPAIN: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 289 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 290 RUSSIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 291 RUSSIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 292 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 293 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 294 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 295 RUSSIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 296 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 297 REST OF EUROPE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 298 REST OF EUROPE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 299 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 300 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 301 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 302 REST OF EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 303 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 304 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 305 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 306 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 308 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 309 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 310 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 312 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 313 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 314 CHINA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 315 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 316 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 317 CHINA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 318 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 319 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 320 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 321 JAPAN: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 322 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 323 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 324 JAPAN: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 325 JAPAN: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 326 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 327 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 328 INDIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 329 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 330 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 331 INDIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 332 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 333 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 334 SOUTH KOREA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 335 SOUTH KOREA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 336 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 337 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 338 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 339 SOUTH KOREA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 340 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 341 AUSTRALIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 342 AUSTRALIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 343 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 344 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 345 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 346 AUSTRALIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 347 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 348 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 349 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 350 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 351 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 352 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 353 REST OF ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 354 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 355 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 356 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 357 LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 358 LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 359 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 360 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 361 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 362 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 363 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 364 BRAZIL: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 365 BRAZIL: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 366 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 367 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 368 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 369 BRAZIL: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 370 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 371 MEXICO: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 372 MEXICO: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 373 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 374 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 375 MEXICO: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 376 MEXICO: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 377 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 378 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 379 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 380 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 381 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 382 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 383 REST OF LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 384 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 385 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 386 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 387 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 388 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 389 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 390 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 391 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 392 MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 393 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 394 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 395 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 396 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 397 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 398 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 399 SAUDI ARABIA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 400 UAE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 401 UAE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 402 UAE: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 403 UAE: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 404 UAE: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 405 UAE: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 406 UAE: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 407 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
  • TABLE 408 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 409 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 410 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY METHOD, 2024-2031 (USD MILLION)
  • TABLE 411 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
  • TABLE 412 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET FOR INDUSTRIAL TESTING, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 413 REST OF MIDDLE EAST & AFRICA: RAPID MICROBIOLOGY TESTING MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 414 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN RAPID MICROBIOLOGY TESTING MARKET, JANUARY 2023-JUNE 2026
  • TABLE 415 RAPID MICROBIOLOGY TESTING MARKET: DEGREE OF COMPETITION
  • TABLE 416 RAPID MICROBIOLOGY TESTING MARKET: REGION FOOTPRINT
  • TABLE 417 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT FOOTPRINT
  • TABLE 418 RAPID MICROBIOLOGY TESTING MARKET: APPLICATION FOOTPRINT
  • TABLE 419 RAPID MICROBIOLOGY TESTING MARKET: END-USER FOOTPRINT
  • TABLE 420 RAPID MICROBIOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 421 RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
  • TABLE 422 RAPID MICROBIOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
  • TABLE 423 RAPID MICROBIOLOGY TESTING MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 424 RAPID MICROBIOLOGY TESTING MARKET: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 425 RAPID MICROBIOLOGY TESTING MARKET: EXPANSIONS, JANUARY 2023-JUNE 2026
  • TABLE 426 BIOMERIEUX: COMPANY OVERVIEW
  • TABLE 427 BIOMERIEUX: PRODUCTS OFFERED
  • TABLE 428 BIOMERIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 429 BIOMERIEUX: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 430 BIOMERIEUX: OTHER DEVELOPMENTS, JANUARY 2023-JUNE 2026
  • TABLE 431 WATERS CORPORATION: COMPANY OVERVIEW
  • TABLE 432 WATERS CORPORATION: PRODUCTS OFFERED
  • TABLE 433 WATERS CORPORATION: PRODUCT APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 434 WATERS CORPORATION: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 435 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 436 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 437 DANAHER CORPORATION: PRODUCT APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 438 DANAHER CORPORATION: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 439 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 440 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 441 ABBOTT LABORATORIES: PRODUCT APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 442 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 443 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 444 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
  • TABLE 445 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 446 BRUKER CORPORATION: COMPANY OVERVIEW
  • TABLE 447 BRUKER CORPORATION: PRODUCTS OFFERED
  • TABLE 448 BRUKER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 449 BRUKER CORPORATION: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 450 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
  • TABLE 451 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
  • TABLE 452 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 453 QUIDELORTHO CORPORATION: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 454 QUIDELORTHO CORPORATION: EXPANSIONS, JANUARY 2023-JUNE 2026
  • TABLE 455 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 456 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 457 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 458 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 459 MERCK KGAA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 460 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW
  • TABLE 461 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
  • TABLE 462 F. HOFFMANN-LA ROCHE LTD: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 463 F. HOFFMANN-LA ROCHE LTD: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 464 CHARLES RIVER LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 465 CHARLES RIVER LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 466 CHARLES RIVER LABORATORIES, INC.: PRODUCT LAUNCHES
  • TABLE 467 CHARLES RIVER LABORATORIES, INC.: DEALS
  • TABLE 468 NEOGEN CORPORATION: COMPANY OVERVIEW
  • TABLE 469 NEOGEN CORPORATION: PRODUCTS OFFERED
  • TABLE 470 NEOGEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JUNE 2026
  • TABLE 471 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 472 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 473 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JUNE 2026
  • TABLE 474 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 475 SHIMADZU CORPORATION: COMPANY OVERVIEW
  • TABLE 476 SHIMADZU CORPORATION: PRODUCTS OFFERED
  • TABLE 477 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2023-JUNE 2026
  • TABLE 478 RAPID MICRO BIOSYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 479 RAPID MICRO BIOSYSTEMS, INC: PRODUCTS OFFERED
  • TABLE 480 RAPID MICRO BIOSYSTEMS, INC.: DEALS, JANUARY 2023-JUNE 2026
  • TABLE 481 DON WHITLEY SCIENTIFIC LIMITED: COMPANY OVERVIEW
  • TABLE 482 GRADIENTECH: COMPANY OVERVIEW
  • TABLE 483 RQMICRO AG: COMPANY OVERVIEW
  • TABLE 484 COLIFAST AS: COMPANY OVERVIEW
  • TABLE 485 HYGIENA LLC: COMPANY OVERVIEW
  • TABLE 486 COPAN DIAGNOSTICS INC.: COMPANY OVERVIEW
  • TABLE 487 PERKINELMER INC.: COMPANY OVERVIEW
  • TABLE 488 HARDY DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 489 CHARM SCIENCES: COMPANY OVERVIEW
  • TABLE 490 R-BIOPHARM: COMPANY OVERVIEW
  • TABLE 491 RAPID MICROBIOLOGY TESTING MARKET: RISK ASSESSMENT

List of Figures

  • FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION
  • FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • FIGURE 3 GLOBAL RAPID MICROBIOLOGY TESTING MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET, 2023-2025
  • FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF RAPID MICROBIOLOGY TESTING MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN RAPID MICROBIOLOGY TESTING MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 8 INCREASING DEMAND FOR RAPID STERILITY TESTING, BIOBURDEN TESTING, AND ENVIRONMENTAL MONITORING TO DRIVE MARKET
  • FIGURE 9 REAGENTS & KITS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 10 GROWTH-BASED SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 11 INDUSTRIAL TESTING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 12 HOSPITALS, CLINICAL LABORATORIES, AND ASCS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 14 RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15 RAPID MICROBIOLOGY TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 16 RAPID MICROBIOLOGY TESTING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 17 RAPID MICROBIOLOGY TESTING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 18 RAPID MICROBIOLOGY TESTING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 19 RAPID MICROBIOLOGY TESTING MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN RAPID MICROBIOLOGY TESTING MARKET
  • FIGURE 21 PATENT ANALYSIS FOR RAPID MICROBIOLOGY TESTING, JANUARY 2015-DECEMBER 2025
  • FIGURE 22 MARKET POTENTIAL OF AI IN RAPID MICROBIOLOGY TESTING MARKET
  • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
  • FIGURE 24 KEY BUYING CRITERIA, BY PRODUCT
  • FIGURE 25 NORTH AMERICA: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 26 ASIA PACIFIC: RAPID MICROBIOLOGY TESTING MARKET SNAPSHOT
  • FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN RAPID MICROBIOLOGY TESTING MARKET, 2023-2025 (USD MILLION)
  • FIGURE 28 RAPID MICROBIOLOGY TESTING MARKET SHARE ANALYSIS, 2025 (GLOBAL)
  • FIGURE 29 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 30 RAPID MICROBIOLOGY TESTING MARKET: COMPANY FOOTPRINT
  • FIGURE 31 RAPID MICROBIOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 32 EV/EBITDA OF KEY VENDORS
  • FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 34 RAPID MICROBIOLOGY TESTING MARKET: BRAND/PRODUCT COMPARISON FOR MALDI-TOF INSTRUMENT
  • FIGURE 35 BIOMERIEUX: COMPANY SNAPSHOT (2025)
  • FIGURE 36 WATERS CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 38 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2025)
  • FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 40 BRUKER CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 41 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 42 SARTORIUS AG: COMPANY SNAPSHOT (2025)
  • FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2025)
  • FIGURE 44 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2025)
  • FIGURE 45 CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 46 NEOGEN CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 47 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 48 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 49 RAPID MICRO BIOSYSTEMS, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 50 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 53 GLOBAL RAPID MICROBIOLOGY TESTING MARKET: REVENUE SHARE ANALYSIS
  • FIGURE 54 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 55 TOP-DOWN APPROACH
  • FIGURE 56 DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!